305 related articles for article (PubMed ID: 22665482)
1. Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.
Mukherjee A; Wu J; Barbour S; Fang X
J Biol Chem; 2012 Jul; 287(30):24990-5000. PubMed ID: 22665482
[TBL] [Abstract][Full Text] [Related]
2. The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.
Ha JH; Ward JD; Varadarajalu L; Kim SG; Dhanasekaran DN
Cell Signal; 2014 Jan; 26(1):122-32. PubMed ID: 24055910
[TBL] [Abstract][Full Text] [Related]
3. Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling.
Ray U; Roy SS
FEBS J; 2018 Feb; 285(3):432-443. PubMed ID: 28971574
[TBL] [Abstract][Full Text] [Related]
4. Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12.
Radhika V; Hee Ha J; Jayaraman M; Tsim ST; Dhanasekaran N
Oncogene; 2005 Jun; 24(28):4597-603. PubMed ID: 15856019
[TBL] [Abstract][Full Text] [Related]
5. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.
Wang W; Wu J; Mukherjee A; He T; Wang XY; Ma Y; Fang X
FASEB J; 2020 Oct; 34(10):13935-13948. PubMed ID: 32851734
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer.
Lee Z; Swaby RF; Liang Y; Yu S; Liu S; Lu KH; Bast RC; Mills GB; Fang X
Cancer Res; 2006 Mar; 66(5):2740-8. PubMed ID: 16510595
[TBL] [Abstract][Full Text] [Related]
8. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
Lee CW; Rivera R; Dubin AE; Chun J
J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic Acid Up-Regulates Hexokinase II and Glycolysis to Promote Proliferation of Ovarian Cancer Cells.
Mukherjee A; Ma Y; Yuan F; Gong Y; Fang Z; Mohamed EM; Berrios E; Shao H; Fang X
Neoplasia; 2015 Sep; 17(9):723-734. PubMed ID: 26476080
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells.
Saunders JA; Rogers LC; Klomsiri C; Poole LB; Daniel LW
Free Radic Biol Med; 2010 Dec; 49(12):2058-67. PubMed ID: 20934509
[TBL] [Abstract][Full Text] [Related]
11. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
[TBL] [Abstract][Full Text] [Related]
12. Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.
Hu YL; Albanese C; Pestell RG; Jaffe RB
J Natl Cancer Inst; 2003 May; 95(10):733-40. PubMed ID: 12759391
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic Acid Induces Aerobic Glycolysis, Lipogenesis, and Increased Amino Acid Uptake in BV-2 Microglia.
Joshi L; Plastira I; Bernhart E; Reicher H; Koyani CN; Madl T; Madreiter-Sokolowski C; Koshenov Z; Graier WF; Hallström S; Sattler W
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671212
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells.
Jeon ES; Heo SC; Lee IH; Choi YJ; Park JH; Choi KU; Park DY; Suh DS; Yoon MS; Kim JH
Exp Mol Med; 2010 Apr; 42(4):280-93. PubMed ID: 20177148
[TBL] [Abstract][Full Text] [Related]
15. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?
Menendez JA; Colomer R; Lupu R
Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
17. LPA3 is a precise therapeutic target and potential biomarker for ovarian cancer.
Zhao P; Yun Q; Li A; Li R; Yan Y; Wang Y; Sun H; Damirin A
Med Oncol; 2022 Jan; 39(2):17. PubMed ID: 34982278
[TBL] [Abstract][Full Text] [Related]
18. Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.
Li H; Ye X; Mahanivong C; Bian D; Chun J; Huang S
J Biol Chem; 2005 Mar; 280(11):10564-71. PubMed ID: 15653692
[TBL] [Abstract][Full Text] [Related]
19. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
20. Endogenous RGS proteins attenuate Galpha(i)-mediated lysophosphatidic acid signaling pathways in ovarian cancer cells.
Hurst JH; Henkel PA; Brown AL; Hooks SB
Cell Signal; 2008 Feb; 20(2):381-9. PubMed ID: 18083345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]